Monisha Sharma MSPH, PhD

Acting Assistant Professor, Global Health, University of Washington

Dr. Monisha Sharma, MSPH, PhD, is an Acting Assistant Professor in the Department of Global Health. She received her Masters in Infectious Disease Epidemiology from Johns Hopkins University and her PhD in Epidemiology from the University of Washington. Her research interests include mathematical modeling and cost-effectiveness analyses of HIV testing and linkage to care interventions in sub-Saharan Africa. She is the Principal Investigator of a K01 award to design an intervention into increase men’s uptake of HIV self-testing and clinic linkage in Uganda. During her joint postdoctoral fellowship with UW and the Harvard School of Public Health, she worked to develop a mathematical model of HIV/HPV co-infection to project the cost-effectiveness of cervical cancer prevention strategies in South Africa. She is currently working on a scale up project of Assisted Partner Notification services in Kenya and collaborates with the Institute for Disease Modeling to project the impact of scaling up point-of-care viral load monitoring for patients on ART in sub-Saharan Africa.

Publications

  1. Roy Paladhi, U, Katz, DA, Otieno, G, Hughes, JP, Thirumurthy, H, Lagat, H et al.. Effectiveness of Using Additional HIV Self-Test Kits as an Incentive to Increase HIV Testing Within Assisted Partner Services. J Acquir Immune Defic Syndr. 2024;96 (5):457-464. doi: 10.1097/QAI.0000000000003455. PubMed PMID:38985443 PubMed Central PMC11237351.
  2. Sharma, M, Mambo, BW, Kingston, H, Otieno, G, Masyuko, S, Lagat, H et al.. Providing HIV-assisted partner services to partners of partners in western Kenya: an implementation science study. J Int AIDS Soc. 2024;27 Suppl 1 (Suppl 1):e26280. doi: 10.1002/jia2.26280. PubMed PMID:38965979 PubMed Central PMC11224583.
  3. Roy Paladhi, U, Katz, DA, Otieno, G, Hughes, JP, Lagat, H, Masyuko, S et al.. Effectiveness of HIV self-testing when offered within assisted partner services in Western Kenya (APS-HIVST Study): a cluster randomized controlled trial. J Int AIDS Soc. 2024;27 Suppl 1 (Suppl 1):e26298. doi: 10.1002/jia2.26298. PubMed PMID:38965976 PubMed Central PMC11224581.
  4. Vitruk, O, Ihnatiuk, AP, Kazanzhy, AP, Shvab, M, Sharma, M, Manhart, LE et al.. Uptake and Persistent Use of HIV Preexposure Prophylaxis Among Key Populations: Results From Ukraine's Scaled National Preexposure Prophylaxis Program. J Acquir Immune Defic Syndr. 2024;96 (3):241-249. doi: 10.1097/QAI.0000000000003432. PubMed PMID:38905475 .
  5. Lagat, HK, Pintye, J, Harrington, E, Houck, S, Kwena, Z, Lenn, M et al.. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial. Trials. 2024;25 (1):394. doi: 10.1186/s13063-024-08206-6. PubMed PMID:38890744 PubMed Central PMC11186170.
Search PubMed

Comments are closed.